NCCP National Cancer Center, Japan

Mission

Discovering the fundamental causes of cancer and realizing its earliest diagnosis and prevention

Developing innovation in medical prevention, diagnosis and treatment

Establishing and making available the most advanced standard of care to all patients

Exploring and providing the best “cancer survivorship” for patients

Gathering and disseminating comprehensive cancer related information to the community

Talent development of all NCC staff members

Recommending new initiatives and policy to the government

Contributing to global society in collaboration with international organizations

History

YEAR

EVENT

1962

Established National Cancer Center

1962

Opened National Cancer Center Hospital East

1997

Completed proton treatment facility

2001

Completed medical genomics building

2004

Opened Research Center for Cancer Prevention and Screening

2005

Opened Research Center for Innovative Oncology

2006

Opened Center for Cancer Control and Information Services

2010

Appointed Independent Administrative Institution

2012

Established Exploratory Oncology Research & Clinical Trial Center

2015

Opened Innovation Center for Supportive, Palliative and Psychosocial Care

2016

Opened Center for Public Health Sciences

Opened Center for Cancer Registries

2018

Established Center for Cancer Genomics and Advanced Therapeutics (C-CAT)

For Details see: The detailed Chronology of Events

History

Instructions for International Patients

Patients meet the following condition, and interested in coming to our hospital for treatment or second opinions, please make an appointment with us through the medical coordinating company.

Who are international patients exactly?

Patients who are not covered by Japan’s national medical insurance resulting from residing out of Japan or other reasons.
Medical fee is calculated 30 yen for one medical point, which is 10 yen for the Japan’s medical-insured patients. (Medical fee is calculated by medical points in Japanese medical system.) It is also taxable.

National Cancer Center Hospital has signed a business cooperation contract with Emergency Assistance Japan, Co., Ltd. (EAJ). To process those patients’ visit, EAJ will get in touch with our Hospital on behalf of the patients. Contact EAJ for an appointment with National Cancer Center Hospital, not contact us directly.

National Cancer Center Hospital does not serve language assistance. Patients who have a Japan’s national medical insurance, but don’t understand the language, please bring a translator with you. Patients who failed to bring one, National Cancer Center Hospital may introduce other hospitals, in terms of safety, where are fully staffed for foreign languages.

To serve smooth and safe clinical work, your understanding is highly appreciated.

About EAJ

Company name

Emergency Assistance Japan, Co., Ltd. (Link to External Site.)

Languages

Japanese, English, Russian, Chinese, Korean, Arabia, Thai, Italian, Indonesian, Bengali and more

Telephone

+81 3 3811 8600

For the first inquiry, Japanese, English, Russian, Chinese languages are available.

EAJ coordinate patients’ visit, thus patients need to sign a contract with EAJ, which means patients need to pay coordinating fee, aside from the medical fee.

E-Mail

mj-infoemergency.co.jp

What EAJ can help

Support for obtaining a medical visa
Paying medial fee to hospitals as patients’ representative
Interpreting, and translating
Arranging accommodation and transportation
24-7 call center during the stay in Japan

Links.

Emergency Assistance Japan, Co., Ltd. (Link to External Site.)

Department

Name	:	National Cancer Center Japan
Location	:	Tsukiji, Tokyo
Date of establishment	:	1962
Organization Type	:	Changed from governmental organization to Independent Administrative Institution (since Apr.1, 2010)
Number of beds	:	1003
Total number of staff	:	3579

Name

NCC Hospital

Location

Tsukiji, Tokyo

Date of establishment

1962

Number of beds

578

Total number of staff

231 staff doctors, 137 resident doctors, 655 nurses

Clinical Departments

Head and Neck Surgery
Head and Neck Medical Oncology
Plastic and Reconstructive Surgery
Breast Surgery
Breast and Medical Oncology
Thoracic Surgery
Thoracic Oncology
Esophageal Surgery
Gastric Surgery
Colorectal Surgery
Gastrointestinal Oncology
Department of Gastroenterology and Endoscopy
Hepatobiliary and Pancreatic Surgery
Hepatobiliary and Pancreatic Oncology
Urology
Gynecology
Musculoskeletal Oncology and Rehabilitation
Hematology
Pediatric Oncology
General Internal Medicine, Dentistry, Cardiovascular Medicine
Anesthesiology
Dept of Intensive Care Medicine
Palliative Medicine
Psycho-Oncology Service
Diagnostic Radiology
Radiation Oncology
Rpathology and Clinical Laboratories
Experimental Therapeutics

Common departments

Rare Cancer Center
Outpatient Treatment Center
Clinical Laboratories
Dept of Clinical Engineering and Medical Technology
Surgical Center
Supportive Care Center
Section of Radiation Safety and Quality Assurance
Nutrition Managemnet Office
Office of Cancer Registry
Medical Information Management Office
Dept of Medical Information
Dept of Pharmacy
Dept of Nursing
Dept of Radiological Technology
Clinical Research Support Office
Certified Nurse Curriculum
Dept of Genetic Medicine and Services

Name

NCC Hospital East

Location

Kashiwa, Chiba Prefecture

Date of establishment

1992

Number of beds

425

Total number of staff

134 staff doctors, 104 resident doctors, 533 nurses

Clinical Departments

Common departments

Name

Research Institute

Location

Tsukiji, Tokyo Kashiwa, Chiba Prefecture

Date of establishment

1962

Total number of staff

395 research staff

Group for Cancer Development and Progression	Division of Molecular Pathology Division of Cellular Signaling Division of Cancer Biology Division of Cancer Evolution Division of Cancer RNA Research
Group for Research of Molecular Functions and Targets	Division of Hematological Malignancy Division of Cancer Stem Cell
Group for Devt of Molecular Diagnostics and Individualized Therapy	Division of Cancer Genomics Division of Genome Biology Division of Brain Tumor Translational Research Division of Molecular Oncology Division of Genome Analysis Platform Development Division of Bioinformatics
Group for Translational Research	Division of Cancer Pathophysiology Division of Cancer Therapeutics
Group for Frontier Science	Division of Molecular Pharmacology Division of Rare Cancer Research Division of Cancer Immunology Division of Medical AI Research and Development Division of Advanced Bioimaging
Fundamental Innovative Oncology Core	Research Support Core Bioresources Core Omics Core Drug Development and Disease Model Core Pathology and Immunology Core

Name	:	Explorately Oncology Research & Clinical Trial Center (EPOC)
Location	:	Tsukiji, Tokyo / Kashiwa, Chiba Prefecture
Date of establishment	:	2005

Name	:

Name	:	Institute for Cancer Control
Location	:	5-1-1, Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan
Date of establishment	:	2021
Number of beds	:	-
Total number of staff	:	100
Vision Health and Dignity for All Mission Work with society, derive evidence to drive cancer control, deliver to all derive glean, examine and present scientific evidence, transforming the world drive make the most of scientific insight, give momentum to cancer control, serving society deliver deliver accurate information to all, implementing and supporting cancer control What we do drive cancer control in Japan, and globally penetrate needs of society, provide evidence and advocate policies expediently and effectively join forces enhancing each other’s forte, work across specialties, maximizing impact with synergy drive projects with dynamism through diligence and constant critical thinking nurture polymath specialists highly professional in public health

Name	:	Center for Cancer Genomics and Advanced Therapeutics (C-CAT)
Location	:	Tsukiji, Tokyo
Date of establishment	:	2018

Total Population	127,000,000
Income Group	High
Total Deaths	1,192,000
Life Expectancy at birth	Total	84
Male	80
Female	87
Cancer Mortality Profile
Age-Standardized Cancer Mortality Trends
Cancer Incidence
Adult Risk Factors	Current tobacco smoking (2011 Data)	Males	34.1%
Females	10.6%
Total	21.8%
Total alcohol per capita consumption, in litres of pure alcohol (2010 Data)	Males	10.4
Females	4.2
Total	7.2
Physical inactivity (2010 Data)	Males	35.1%
Females	42%
Total	38.7%
Obesity (2014 Data)	Males	35.1%
Females	42%
Totals	38.7%
Household solid fuel use (2012 Data)	Males	NA
Females	NA
Total	0%
Cancer Plans, Monitoring, and Surveillance	Has an operational cancer policy/strategy/action plan	Yes
Has a cancer registry
Scope	Population-based
Coverage	Subnational
Last Year of Data	2008
Cancer Primary Prevention Policies	Tobacco Control	Has an operational policy, strategy or action plan to reduce the burden of tobacco use	Yes
Smoke-free legislation	Up to two public places completely smoke-free
Tobacco dependence treatment	NRT and/or some cessation services (neither cost-covered)
Warning labels	Medium size warnings missing some appropriate characteristics OR large warnings missing many appropriate characteristics
Bans on advertising, promotion and sponsorship	Complete absence of ban, or ban that does not cover national television, radio and print media
Tobacco taxes	51-75% of retail price is tax
Overweight and obesity prevention and control	Has an operational policy, strategy or action plan for reducing overweight/obesity	Yes
Physical inactivity prevention and control	Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote physical activity	Yes
Harmful use of alcohol prevention and control	Has an operational policy, strategy or action plan to reduce the harmful use of alcohol	Yes
National Immunization	Human Papillomavirus vaccination schedule	13 years (x3)
Hepatitis B vaccination schedule	NA
Hepatitis B vaccination coverage, infants	NA
Cancer Screening and Early Detection	Cervical Cancer	Cervical cytology (PAP)	Generally available at the public primary health care level
Acetic Acid Vizualization (VIA)	Generally available at the public primary health care level
Breast Cancer	Breast palpation / clinical breast exam (CBE)	Generally available at the public primary health care level
Mammogram	Generally available at the public primary health care level
Colorectal Cancer	Faecal occult blood test or faecal immunological test	Generally available at the public primary health care level
Bowel cancer screening by exam or colonoscopy	Generally available at the public primary health care level
Cancer Treatment and Palliative Care	Radiotherapy	Generally available in the public health system
Total high energy teletherapy units / million inhabitants	7
Number of radiotherapy centres	792
Number of radiation oncologists	871
Chemotherapy (medicines not specified)	Generally available in the public health system
Oral morphine (formulation not specified)	Generally available in the public health system
Non-methadone morphine equivalent consumption per cancer death (mg)	NA
Community/home care for people with advanced stage cancer and other NCDs	Generally available
REMARKS
SOURCE	Extracted from: WHO Cancer Country Profiles 2014 (https://www.who.int/cancer/country-profiles/jpn_en.pdf?ua=1) as of 2019/05/30

Total Population

127,000,000

Income Group

High

Total Deaths

1,192,000

Life Expectancy at birth

Total

Male

Female

Cancer Mortality Profile

Age-Standardized Cancer Mortality Trends

Cancer Incidence

Adult Risk Factors

Current tobacco smoking (2011 Data)

Males

34.1%

Females

10.6%

Total

21.8%

Total alcohol per capita consumption, in litres of pure alcohol (2010 Data)

Males

10.4

Females

4.2

Total

7.2

Physical inactivity (2010 Data)

Males

35.1%

Females

42%

Total

38.7%

Obesity (2014 Data)

Males

35.1%

Females

42%

Totals

38.7%

Household solid fuel use (2012 Data)

Males

Females

Total

Cancer Plans, Monitoring, and Surveillance

Has an operational cancer policy/strategy/action plan

Yes

Has a cancer registry

Scope

Population-based

Coverage

Subnational

Last Year of Data

2008

Cancer Primary Prevention Policies

Tobacco Control

Has an operational policy, strategy or action plan to reduce the burden of tobacco use

Yes

Smoke-free legislation

Up to two public places completely smoke-free

Tobacco dependence treatment

NRT and/or some cessation services (neither cost-covered)

Warning labels

Medium size warnings missing some appropriate characteristics OR large warnings missing many appropriate characteristics

Bans on advertising, promotion and sponsorship

Complete absence of ban, or ban that does not cover national television, radio and print media

Tobacco taxes

51-75% of retail price is tax

Overweight and obesity prevention and control

Has an operational policy, strategy or action plan for reducing overweight/obesity

Yes

Physical inactivity prevention and control

Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote physical activity

Yes

Harmful use of alcohol prevention and control

Has an operational policy, strategy or action plan to reduce the harmful use of alcohol

Yes

National Immunization

Human Papillomavirus vaccination schedule

13 years (x3)

Hepatitis B vaccination schedule

Hepatitis B vaccination coverage, infants

Cancer Screening and Early Detection

Cervical Cancer

Cervical cytology (PAP)